Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunction.
Lin AZ, Fu X, Jiang Q, Zhou X, Hwang SH, Yin HH, Ni KD, Pan QJ, He X, Zhang LT, Meng YW, Liu YN, Hammock BD, Liu JY.
Lin AZ, et al. Among authors: pan qj.
Proc Natl Acad Sci U S A. 2024 Nov 26;121(48):e2409841121. doi: 10.1073/pnas.2409841121. Epub 2024 Nov 18.
Proc Natl Acad Sci U S A. 2024.
PMID: 39556751